Carregant...
PPARγ agonists delay age‐associated metabolic disease and extend longevity
Aging leads to a number of disorders caused by cellular senescence, tissue damage, and organ dysfunction. It has been reported that anti‐inflammatory and insulin‐sensitizing compounds delay, or reverse, the aging process and prevent metabolic disorders, neurodegenerative disease, and muscle atrophy,...
Guardat en:
| Publicat a: | Aging Cell |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7681041/ https://ncbi.nlm.nih.gov/pubmed/33219735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acel.13267 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|